FDA Clearance Tracker · K253957
HemosIL Silica Clotting Time
Last checked: Nov 20, 2026Latest source record: Jan 9, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jan 9, 2026
Substantially Equivalent
Time to decision
30 days
Received Dec 10, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K253957
- Device name
- HemosIL Silica Clotting Time
- Applicant
- Instrumentation Laboratory (IL) Co.
- Applicant location
- Bedford, MA
- Received
- Dec 10, 2025
- Decided
- Jan 9, 2026
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Activated Partial Thromboplastin (GFO)
- Device class
- Class II
- Regulation
- 21 CFR 864.7925
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GFO. The earliest in FDA's data is K760318, decided Aug 3, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K253957
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Instrumentation Laboratory (IL) Co.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260551 · Decided Mar 20, 2026 · 30 days after receipt
Device type: Test, Time, Partial Thromboplastin (GGW) · Laboratory Medicine & Pathology
K251968 · Decided Jul 24, 2025 · 28 days after receipt
Device type: System, Fibrinogen Determination (KQJ) · Laboratory Medicine & Pathology
K243374 · Decided Jan 28, 2025 · 90 days after receipt
Device type: Platelet Factor 4 Radioimmunoassay (LCO) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.